Part 2 Fees relating to marketing authorisationsF1

United Kingdom Repealed

1. 7Fees for specified pharmaceutical applications
2. 8Decentralised pharmaceutical application where the United Kingdom is the reference member State
3. 9Application for a marketing authorisation for an immunological product
4. 10Decentralised immunological application where the United Kingdom is the reference member State
5. 11Application for a marketing authorisation using identical data
6. 12Application for a provisional marketing authorisation (pharmaceutical)
7. 13Fees for an application for a provisional marketing authorisation (immunological)
8. 14Fee for the conversion from a provisional to a full marketing authorisation
9. 15Application for a marketing authorisation relating to a parallel import
10. 16Application for a variation
11. 17Application for a variation to a marketing authorisation that has been issued in other member States
12. 18Application for an extension to a marketing authorisation
13. 19Decentralised application for an extension where the United Kingdom is the reference member State
14. 20Provision of information relating to the recognition of a United Kingdom marketing authorisation
15. 21Application for the renewal of a national marketing authorisation
16. 22Application for the renewal of a marketing authorisation granted in more than one member State
17. 23Registration of a homeopathic remedy
18. 24Annual fees for marketing authorisations
19. 25Auditor’s certificate
20. 26Late payment of annual fees